| Ytd | -15.38% | |
| 1y | -3.67% |
| Open | 191.97 | Prev Close | 190.48 | Low | 190.62 | High | 196.00 | Mkt Cap | 137.11B |
| Vol | 3.09M | Avg Vol | 4.58M | EPS | 5.15 | P/E | 37.62 | Forward P/E | 21.04 |
| Beta | 0.83 | Short Ratio | 2.72 | Inst. Own | 84.61% | Dividend | 1.60 | Div Yield | 0.84 |
| Ex Div Date | 06-26 | Earning | 07-21 | 50-d Avg | 178.61 | 200-d Avg | 203.94 | 1yr Est | 242.35 |
DHR News
WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (
Dan Deming talks joins today's Big 3 and highlights JPMorgan Chase (JPM) as shares touch new record
Danaher (DHR) is looking like an interesting pick from a technical perspective, as the company reach
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and othe
Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page a
Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on ana
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, includin
Piper Sandler analyst David Westenberg initiates coverage on Danaher (NYSE:DHR) with a Neutral ra